Entrada Share Price

Entrada Share Price

NASDAQ: TRDA | Micro Cap | Healthcare
$5.04
+$0.05 (1.10%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Entrada Stock Performance

Open
$4.90
Prev. Close
$4.99
Circuit Range
N/A
Day Range
$4.90 - $5.41
Year Range
$4.11 - $16.43
Volume
25,465
Average Traded
$5.21

Entrada Share Price Today

As of 19 November 2026, Entrada Therapeutics, Inc.'s share price is $5.04. The stock opened at $4.90, compared to its previous close of $4.99. During today's trading session, Entrada Therapeutics, Inc.'s share price traded between $4.90 and $5.41, with an average price of $5.16. Over the past 52 weeks, the stock has recorded a high of $16.43 and a low of $4.11. In terms of performance, Entrada Therapeutics, Inc.'s share price has declined by 28.51% over the last six months and is down 50.90% on a year-on-year basis.

Entrada Share Price Chart

Line chart of the Entrada price trend over the selected period. The price rose overall, ranging from 4.87 to 5.49, ending at 5.04.
$4.90$5.41
L
Show Current Price
H

Entrada Stock Fundamentals & Key Indicators

Market Cap
$208.51M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.12
Revenue (TTM)
$25.42B
Return On Equity (TTM)
-81.37%
Profit Margin
-565.50%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-1.48%

Entrada Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.30$0.88$0.90$0.91
Net Profit-$39.16-$39.72-$42.76-$39.74
Net Profit Margin-3012.31%-4513.64%-4751.11%-4367.03%
Income ChangeN/A-1.43%-7.65%7.06%

Entrada Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$129.01$210.78$25.42
Net Profit-$94.62-$6.69$65.63-$143.75
Net Profit MarginN/A-5.19%31.14%-565.50%
Income ChangeN/A92.93%1081.02%-319.03%

Entrada Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets71.1386.2899.4242.18
Current Assets306.25440.04369.77209.88
Total Assets377.38526.32469.19252.06
Non Current Liabilities46.7958.1668.0417.53
Current Liabilities24.4539.48158.821.97
Total Liabilities71.2597.64226.8339.5
Shareholders' Equity306.13428.68242.36212.55

Entrada Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-128.51-41.56139.8-93.79
Investing116.81-27.8-138.4-148.65
Financing0.89102.9621.040.48

About Entrada

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Entrada Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.61
$5.04
+11.03%
Oct 2026
$6.19
$4.54
-28.47%
Sep 2026
$7.01
$6.34
-12.55%
Aug 2026
$6.77
$7.25
+6.62%
Jul 2026
$7.42
$6.80
-7.73%
Jun 2026
$6.98
$7.37
+4.54%
May 2026
$13.36
$7.05
-47.78%
Apr 2026
$13.10
$13.50
+6.85%
Mar 2026
$11.61
$12.63
+5.82%
Feb 2026
$11.44
$11.94
+4.51%
Jan 2026
$10.29
$11.43
+11.14%
Dec 2025
$10.16
$10.28
+0.15%

Entrada Share Price FAQs